布托啡诺联合氟比洛芬酯预处理通过ANG（1-7）对小鼠肢体缺血再灌注诱发肾损伤的保护作用及机制

doi:10.3969/j.issn.1007-3205.2023.01.002

河北医科大学学报 ›› 2023, Vol. 44 ›› Issue (1): 5-9,41.doi: 10.3969/j.issn.1007-3205.2023.01.002

布托啡诺联合氟比洛芬酯预处理通过ANG（1-7）对小鼠肢体缺血再灌注诱发肾损伤的保护作用及机制

1.河北省张家口市第二医院麻醉科，河北张家口 075000；2.河北北方学院基础医学院病理生理学教研室，
河北张家口 075000；3.河北省张家口市第二医院手术室，河北张家口 075000

出版日期:2023-01-25 发布日期:2023-01-17
作者简介:李海英(1970-)，女，河北张家口人，河北省张家口市第二医院主治医师，医学硕士，从事临床麻醉学研究。
基金资助:
张家口市重点研发计划项目（2121084D）

Protective effect and mechanism of butorphanol combined with flurbiprofen axetil preconditioning on renal injury induced by limb ischemia-reperfusion in mice through ANG (1-7)

1.Department of Anesthesiology, the Second Hospital of Zhangjiakou City, Hebei Province, Zhangjiakou
075000, China; 2.Department of Pathophysiology, Hebei North University, Hebei Province,
Zhangjiakou 075000, China; 3.Department of Operating Room, the Second Hospital of
Zhangjiakou City, Hebei Province, Zhangjiakou 075000, China

Online:2023-01-25 Published:2023-01-17

摘要/Abstract

摘要： 目的探究布托啡诺联合氟比洛芬酯预处理通过血管紧张素（1-7）［Angiotensin （1-7），ANG（1-7）］对小鼠肢体缺血再灌注诱发肾损伤的保护作用及对炎症通路TNF超家族成员14配体（TNF superfamily member 14 ligand，LIGHT）/ TNF超家族成员14（TNF superfamily member 14,HVEM）的影响。
方法将45只SPF级BABL/c小鼠随机分为对照组（n=15）、模型组（n=15）、试验组（n=15），除对照组外，建立肢体缺血再灌注诱发肾损伤模型，试验组造模前采用布托啡诺联合氟比洛芬酯预处理12 h，对照组和模型组给予等量生理盐水。HE染色确认各组小鼠肾脏组织病理水平及病理评分，大生化分析确定肾功能指标血清肌酐（serum creatinine，Scr）和尿素氮(urea nitrogen,BUN)水平，检测外周血及肾组织ANG（1-7）表达水平，qPCR和Western blot 检测肾脏组织LIGHT和HVEM mRNA和蛋白表达水平。
结果与对照组比较，模型组小鼠肾组织损伤升高，病理评分升高，Scr和BUN表达升高，ANG（1-7）表达水平降低，LIGHT和HVEM表达水平升高；与模型组比较，试验组小鼠模型组小鼠肾组织损伤降低，病理评分减低，Scr和BUN表达降低，ANG（1-7）表达水平升高，LIGHT和HVEM表达水平降低（P＜0.05）。
结论布托啡诺联合氟比洛芬酯预处理对小鼠肢体缺血再灌注诱发肾损伤具有保护作用，其机制可能通过影响ANG（1-7）干预炎症通路LIGHT/HVEM信号蛋白表达相关。

关键词: 再灌注损伤, 肾损伤, 布托啡诺, 氟比洛芬酯

Abstract: Objective To investigate the protective effect of butorphanol combined with flurbiprofen axetil preconditioning on renal injury induced by limb ischemia-reperfusion in mice through angiotensin (1-7) ［ANG (1-7)］ and its effect on TNF superfamily member 14 ligand (LIGHT)/TNF superfamily member 14 (HVEM) in the inflammatory pathway.
Methods Forty-five SPF grade BABL/c mice were randomly divided into control group (n=15), model group (n=15), and experimental group (n=15). Except the control group, renal injury model induced by limb ischemia-reperfusion was established. The experimental group was pretreated with butorphanol and flurbiprofen axetil for 12 h before modeling, and the control group and model group were given the same amount of normal saline. HE staining was used to confirm the pathological level and pathological score of kidney tissues of mice in each group. Biochemical analysis was used to determine the levels of serum creatinine (Scr) and urea nitrogen (BUN), and the levels of ANG (1-7) expression in peripheral blood and kidney tissues. The mRNA and protein expression levels of LIGHT and HVEM in kidney tissues were detected by qPCR and Western blot.
Results Compared with the control group, the renal tissue injury, pathological score, and the expression of Scr and BUN decreased, the expression level of ANG (1-7) decreased, and LIGHT and HVEM increased in the model group (P＜0.01). Compared with the model group, the renal tissue injury, pathological score, and the expression of Scr and BUN decreased, the expression level of ANG (1-7) increased, and LIGHT and HVEM decreased (P＜0.01).
Conclusion Butorphanol combined with flurbiprofen axetil preconditioning has a protective effect on renal injury induced by limb ischemia-reperfusion in mice, and its mechanism may be related to the intervention of ANG (1-7) on the expression of LIGHT/HVEM signal pathway proteins.

Key words: reperfusion injury, renal injury, butorphanol, flurbiprofen axetil

李海英, 张玉平, 张青, 张立民 . 布托啡诺联合氟比洛芬酯预处理通过ANG（1-7）对小鼠肢体缺血再灌注诱发肾损伤的保护作用及机制 [J]. 河北医科大学学报, 2023, 44(1): 5-9,41.

LI Hai-ying, ZHANG Yu-ping, ZHANG Qing, ZHANG Li-min. Protective effect and mechanism of butorphanol combined with flurbiprofen axetil preconditioning on renal injury induced by limb ischemia-reperfusion in mice through ANG (1-7) [J]. Journal of Hebei Medical University, 2023, 44(1): 5-9,41.

[1]	李海英, 张玉平, 邓秀丽. 布托啡诺联合氟比洛芬酯预防止血带致肢体缺血再灌注损伤临床观察 [J]. 河北医科大学学报, 2023, 44(2): 230-235.
[2]	杜菲, 郑丽环, 王征, 房健健, 焦清海. miR-142-3p、miR-216a、miR-107-5p在ICU血液净化AKI患者中的表达及对疗效的评估价值分析 [J]. 河北医科大学学报, 2022, 43(8): 920-925.
[3]	王瑞, 张玲叶, 杜艳华. Sigma-1受体激动剂PRE-084对大鼠心肌缺血再灌注损伤的保护作用[J]. 河北医科大学学报, 2022, 43(4): 377-380.
[4]	罗志中, 冯凯, 罗雅琪. 甘露醇对缺血再灌注大鼠脑保护作用的机制研究 [J]. 河北医科大学学报, 2022, 43(11): 1244-1249.
[5]	孙原, 侯晓冬, 杨延雯, 李艳玲, 李弘, 石秋艳. 增强自噬水平对脑缺血预处理神经保护机制的影响[J]. 河北医科大学学报, 2021, 42(7): 750-753,764,封三.
[6]	宋京花, 贾红艳, 邵天鹏, 柳志宝, 赵元平. 氢气对蛛网膜下腔出血致急性肾损伤大鼠的保护作用[J]. 河北医科大学学报, 2021, 42(6): 624-630.
[7]	李燕, 黄庆生, 方明星, 张丽霞, 郭建英, 王智勇. 黏附因子联合肾阻力指数对脓毒症相关性肾损伤的早期肾功能恢复的预测价值[J]. 河北医科大学学报, 2021, 42(12): 1387-1391,1396.
[8]	杨震, 唐克菲, 陈小珠, 刘淑军, 杜艳华. 高血压肾损伤患者肾血流指标及炎症趋化因子与胰岛素抵抗的关系探究[J]. 河北医科大学学报, 2021, 42(12): 1397-1400,1410.
[9]	韩碧翠1，张福1，林少强2. AKI肾穿刺活检术后肾周血肿与术前透析干预相关性研究[J]. 河北医科大学学报, 2020, 41(9): 1029-1032.
[10]	黄吉霞1，高鹏志2*，赵臣3，李晓娜2，魏伟2，牛晓蕾2. JNK3过表达促进心肌缺血再灌注损伤#br#[J]. 河北医科大学学报, 2020, 41(2): 200-203.
[11]	吴春涛. NGAL、Cys C在瓣膜病换瓣术后早期诊断急性肾损伤的意义[J]. 河北医科大学学报, 2019, 40(12): 1388-1392.
[12]	郭雪晶1，黄鹰1，张羽2*. Sema 3A、KIM-1和Cys C在子痫前期患者肾功能损害早期诊断中的临床价值[J]. 河北医科大学学报, 2019, 40(11): 1285-1289.
[13]	于国霞1，杨俊慧2，霍宏昌1，王〓磊3，王〓切3*. GPX-1在大鼠肝缺血再灌注损伤模型的表达变化[J]. 河北医科大学学报, 2019, 40(1): 7-10,15.
[14]	于国霞1，霍宏昌1，王素玲2，王〓切3*. 肾缺血再灌注损伤大鼠肺内谷胱甘肽过氧化物酶1的表达变化[J]. 河北医科大学学报, 2017, 37(8): 873-877.
[15]	龚〓淼1，张〓雷1，赵春芳1,李〓莉1，张亚楠1,任广伟2*. 普罗布考对小鼠肾缺血再灌注损伤的保护作用与机制#br#[J]. 河北医科大学学报, 2017, 37(5): 497-500,505.

布托啡诺联合氟比洛芬酯预处理通过ANG（1-7）对小鼠肢体缺血再灌注诱发肾损伤的保护作用及机制

Protective effect and mechanism of butorphanol combined with flurbiprofen axetil preconditioning on renal injury induced by limb ischemia-reperfusion in mice through ANG (1-7)

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价